Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-08
DOI
10.1038/s41467-020-20140-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TP53 Mutation by CRISPR System Enhances the Malignant Potential of Colon Cancer
- (2019) Sho Watanabe et al. MOLECULAR CANCER RESEARCH
- The E3 ubiquitin ligase UBR 5 interacts with the H/ ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells
- (2019) Isabel Saez et al. FEBS LETTERS
- Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
- (2018) Shan-Shan Li et al. Journal of Gynecologic Oncology
- A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing
- (2018) Ruoji Zhou et al. Stem Cell Research
- Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
- (2018) Sarwish Rafiq et al. NATURE BIOTECHNOLOGY
- tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish
- (2018) Myron S Ignatius et al. eLife
- Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis
- (2017) Xia Yuan et al. GYNECOLOGIC ONCOLOGY
- β-catenin downregulates Dicer to promote ovarian cancer metastasis
- (2017) S K Y To et al. ONCOGENE
- Immune Cell Population in Ovarian Tumor Microenvironment
- (2017) Dong Li Cai et al. Journal of Cancer
- MOAP-1, UBR5 and cisplatin resistance in ovarian cancer
- (2017) Scott T. Eblen et al. Translational Cancer Research
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
- (2016) Mingzhu Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin
- (2016) K Matsuura et al. ONCOGENE
- Use of a Conditional Ubr5 Mutant Allele to Investigate the Role of an N-End Rule Ubiquitin-Protein Ligase in Hedgehog Signalling and Embryonic Limb Development
- (2016) Elaine Kinsella et al. PLoS One
- ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
- (2015) Juan R. Cubillos-Ruiz et al. CELL
- A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
- (2015) Mythili Koneru et al. Journal of Translational Medicine
- Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer
- (2015) R. F. Shearer et al. MOLECULAR CANCER RESEARCH
- Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells
- (2015) Pui-Wah Choi et al. Oncotarget
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Bone marrow endothelium-targeted therapeutics for metastatic breast cancer
- (2014) Junhua Mai et al. JOURNAL OF CONTROLLED RELEASE
- β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
- (2014) S Condello et al. ONCOGENE
- Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer
- (2014) Emily K. Colvin Frontiers in Oncology
- CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice
- (2013) S. Jacquelin et al. BLOOD
- EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer
- (2013) Amber Bradley et al. CARCINOGENESIS
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
- (2013) Silke Reinartz et al. INTERNATIONAL JOURNAL OF CANCER
- EDD induces cell cycle arrest by increasing p53 levels
- (2012) Veronique A.J. Smits CELL CYCLE
- Polarization of Tumor-Associated Macrophages: A Novel Strategy for Vascular Normalization and Antitumor Immunity
- (2011) Yuhui Huang et al. CANCER CELL
- EDD Inhibits ATM-mediated Phosphorylation of p53
- (2011) Shiyun Ling et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis
- (2011) N. Dompe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The EDD E3 ubiquitin ligase ubiquitinates and up-regulates β-catenin
- (2010) Avital Hay-Koren et al. MOLECULAR BIOLOGY OF THE CELL
- Multicellular spheroids in ovarian cancer metastases: Biology and pathology
- (2009) Kristy Shield et al. GYNECOLOGIC ONCOLOGY
- Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids
- (2008) Sylvain L'Espérance et al. BMC GENOMICS
- The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
- (2008) P M O'Brien et al. BRITISH JOURNAL OF CANCER
- Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype
- (2008) Katharine L. Sodek et al. INTERNATIONAL JOURNAL OF CANCER
- Cadherin switching
- (2008) M. J. Wheelock et al. JOURNAL OF CELL SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started